Check out these featured Drug Topics expert interviews from June 2024.
Patient Trust, Active Listening Key to Enhancing Men's Health Care
Patrick Alonso, PharmD, CPh, owner and manager of BlueZone Health Care Advocates and co-host of the Men’s Health Unscripted podcast, talks about how health care providers can build trust with male patients and what screenings men at different ages should be having.
Discussing the FDA Panel’s Rejection of MDMA-Assisted Therapy for PTSD
Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discussed problems that he saw during the FDA’s Psychopharmacologic Drugs Advisory Committee meeting on MDMA to treat PTSD, the issue of functional unblinding, stereotypes of psychedelics being gateway drugs, and the fact that patients with PTSD desperately need new treatment options.
Does Chocolate Trigger Migraines?
Shivang Joshi, MD, MPH, RPh, FAHS, director of headache medicine and director of clinical research at Community Neuroscience Services, as well as Association of Migraine Disorders board member and Shades for Migraine medical ambassador, debunks common migraine myths, such as those related to caffeine, stress, and sugary foods.
Q&A: How to Manage Burnout in the Pharmacy
Joanna Lewis, PharmD, MBA, wellness writer and advocate, discusses how pharmacists can reclaim their well-being and reduce feelings of burnout by prioritizing self-care, establishing work-life boundaries, and leaning on support systems.
Q&A: How to Become a Pharmacist
Emily Bellan, a PharmD candidate at Duquesne University, talks about her path to becoming a pharmacist, how to apply for pharmacy school, post-graduate opportunities for students in the field, and more.
Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.